Kitazato Corporation (TYO:368A)

Market Cap	55.08B -3.7%
Revenue (ttm)	11.53B +11.0%
Net Income	4.16B +12.0%
EPS	103.93 +12.0%
Shares Out	40.00M
PE Ratio	13.25
Forward PE	12.63
Dividend	41.00 (2.98%)
Ex-Dividend Date	Mar 30, 2026

Volume	71,500
Open	1,380.00
Previous Close	1,382.00
Day's Range	1,373.00 - 1,388.00
52-Week Range	1,155.00 - 1,695.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About Kitazato

Kitazato Corporation researches, develops, manufactures, and markets medical devices, reagents, and related products for fertility treatment. It offers needles, catheters and cannulas, vitrification media and equipment, sperm processing medium/tools, IVF medium products, micro tools, and labware products. The company was formerly known as Kitazato Biopharma Co., Ltd. The company was founded in 1998 and is based in Shizuoka, Japan. Kitazato Corporation is a subsidiary of Kitasato Shoji Co., Ltd.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1998
• Employees: 83
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 368A

Financial Performance

In fiscal year 2026, Kitazato's revenue was 10.95 billion, an increase of 6.26% compared to the previous year's 10.30 billion. Earnings were 3.90 billion, an increase of 2.82%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 6, 2026

Data Sources Report a data error